An Study to Investigate the Efficacy of Delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) in Multiple Sclerosis

Clinical trial NCT01610713. Status: COMPLETED. Sponsor: Jazz Pharmaceuticals